These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 26116441)

  • 1. Identification of key residues involved in the activation and signaling properties of dopamine D3 receptor.
    Kota K; Kuzhikandathil EV; Afrasiabi M; Lacy B; Kontoyianni M; Crider AM; Song D
    Pharmacol Res; 2015 Sep; 99():174-84. PubMed ID: 26116441
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification and characterization of a novel class of atypical dopamine receptor agonists.
    Kuzhikandathil EV; Kortagere S
    Pharm Res; 2012 Aug; 29(8):2264-75. PubMed ID: 22547031
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Behavioral and neurochemical effects of the preferential dopamine D3 receptor agonist cis-8-OH-PBZI.
    Fink-Jensen A; Nielsen EB; Hansen L; Scheideler MA
    Eur J Pharmacol; 1998 Jan; 342(2-3):153-61. PubMed ID: 9548380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The preferential dopamine D3 receptor agonist cis-8-OH-PBZI induces limbic Fos expression in rat brain.
    Scheideler MA; Martin J; Hohlweg R; Rasmussen JS; Naerum L; Ludvigsen TS; Larsen PJ; Korsgaard N; Crider AM; Ghosh D; Cruse SF; Fink-Jensen A
    Eur J Pharmacol; 1997 Nov; 339(2-3):261-70. PubMed ID: 9473144
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The tolerance property of human D3 dopamine receptor is determined by specific amino acid residues in the second cytoplasmic loop.
    Westrich L; Kuzhikandathil EV
    Biochim Biophys Acta; 2007 Dec; 1773(12):1747-58. PubMed ID: 17662480
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro and in vivo characterization of the agonist-dependent D3 dopamine receptor tolerance property.
    Cote SR; Kuzhikandathil EV
    Neuropharmacology; 2014 Apr; 79():359-67. PubMed ID: 24316466
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An amino acid residue in the second extracellular loop determines the agonist-dependent tolerance property of the human D3 dopamine receptor.
    Gil-Mast S; Kortagere S; Kota K; Kuzhikandathil EV
    ACS Chem Neurosci; 2013 Jun; 4(6):940-51. PubMed ID: 23477444
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of tolerance in D3 dopamine receptor signaling is accompanied by distinct changes in receptor conformation.
    Westrich L; Gil-Mast S; Kortagere S; Kuzhikandathil EV
    Biochem Pharmacol; 2010 Mar; 79(6):897-907. PubMed ID: 19879251
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification and characterization of novel properties of the human D3 dopamine receptor.
    Kuzhikandathil EV; Westrich L; Bakhos S; Pasuit J
    Mol Cell Neurosci; 2004 May; 26(1):144-55. PubMed ID: 15121186
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel roles for β-arrestins in the regulation of pharmacological sequestration to predict agonist-induced desensitization of dopamine D3 receptors.
    Min C; Zheng M; Zhang X; Caron MG; Kim KM
    Br J Pharmacol; 2013 Nov; 170(5):1112-29. PubMed ID: 23992580
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An intracellular loop 2 amino acid residue determines differential binding of arrestin to the dopamine D2 and D3 receptors.
    Lan H; Teeter MM; Gurevich VV; Neve KA
    Mol Pharmacol; 2009 Jan; 75(1):19-26. PubMed ID: 18820126
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction of novel hybrid compounds with the D3 dopamine receptor: Site-directed mutagenesis and homology modeling studies.
    Kortagere S; Cheng SY; Antonio T; Zhen J; Reith ME; Dutta AK
    Biochem Pharmacol; 2011 Jan; 81(1):157-63. PubMed ID: 20833147
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Altered behavioral response to dopamine D3 receptor agonists 7-OH-DPAT and PD 128907 following repetitive amphetamine administration.
    Richtand NM; Welge JA; Levant B; Logue AD; Hayes S; Pritchard LM; Geracioti TD; Coolen LM; Berger SP
    Neuropsychopharmacology; 2003 Aug; 28(8):1422-32. PubMed ID: 12700693
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Repeated imipramine treatment enhances the 7-OH-DPAT-induced hyperactivity in rats: the role of dopamine D2 and D3 receptors.
    Rogóz Z; Skuza G
    Pol J Pharmacol; 2001; 53(6):571-6. PubMed ID: 11985330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of dopamine D3 agonists and antagonists in a nonhuman primate model of tardive dyskinesia.
    Malik P; Andersen MB; Peacock L
    Pharmacol Biochem Behav; 2004 Aug; 78(4):805-10. PubMed ID: 15301939
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Agonist-specific voltage sensitivity at the dopamine D2S receptor--molecular determinants and relevance to therapeutic ligands.
    Sahlholm K; Barchad-Avitzur O; Marcellino D; Gómez-Soler M; Fuxe K; Ciruela F; Arhem P
    Neuropharmacology; 2011; 61(5-6):937-49. PubMed ID: 21752340
    [TBL] [Abstract][Full Text] [Related]  

  • 17. D3 dopamine receptor signals to activation of phospholipase D through a complex with Rho.
    Everett PB; Senogles SE
    J Neurochem; 2010 Feb; 112(4):963-71. PubMed ID: 20021566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of unconditioned behavioral effects of dopamine D3/D2 receptor agonists.
    Geter-Douglass B; Katz JL; Alling K; Acri JB; Witkin JM
    J Pharmacol Exp Ther; 1997 Oct; 283(1):7-15. PubMed ID: 9336302
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dopamine D3 receptor-preferring agonists increase dendrite arborization of mesencephalic dopaminergic neurons via extracellular signal-regulated kinase phosphorylation.
    Collo G; Zanetti S; Missale C; Spano P
    Eur J Neurosci; 2008 Oct; 28(7):1231-40. PubMed ID: 18973551
    [TBL] [Abstract][Full Text] [Related]  

  • 20. D2S, D2L, D3, and D4 dopamine receptors couple to a voltage-dependent potassium current in N18TG2 x mesencephalon hybrid cell (MES-23.5) via distinct G proteins.
    Liu LX; Burgess LH; Gonzalez AM; Sibley DR; Chiodo LA
    Synapse; 1999 Feb; 31(2):108-18. PubMed ID: 10024007
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.